MAPPIT: A protein interaction toolbox built on insights in cytokine receptor signaling

Cytokine and Growth Factor Reviews

Volumn 22, Issue 5-6, 2011, Pages 321-329

  Lievens, Sam ^a,b   Peelman, Frank ^a,b   De Bosscher, Karolien ^a,b   Lemmens, Irma ^a,b   Tavernier, Jan ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Interactomics; Mammalian two hybrid; MAPPIT; MASPIT; Protein protein interaction

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; HYBRID PROTEIN; JANUS KINASE; LEPTIN RECEPTOR; STAT PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; HUMAN; MAMALIAN PROTEIN PROTEIN INTERACTION TRAP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM;

ANIMALS; HUMANS; PROTEIN INTERACTION MAPPING; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 82955163295     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2011.11.001     Document Type: Review

References (58)

1. Nusinzon I., Horvath C.M. Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Sci STKE 2005, 2005:re11.
2. Icardi L, Lievens S, Mori R, Piessevaux J, De Cauwer L, De Bosscher K, et al. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACs) 1 and 2. FASEB J, in press.
3. Eyckerman S., Lemmens I., Lievens S., Van der Heyden J., Verhee A., Vandekerckhove J., et al. Design and use of a mammalian protein-protein interaction trap (MAPPIT). Sci STKE 2002, 2002:pl18.
4. Tavernier J., Eyckerman S., Lemmens I., Van der Heyden J., Vandekerckhove J., Van Ostade X. MAPPIT: a cytokine receptor-based two-hybrid method in mammalian cells. Clin Exp Allergy 2002, 32:1397-1404.
5. Eyckerman S., Tavernier J. Methods to map protein interactions in mammalian cells: different tools to address different questions. Eur Cytokine Netw 2002, 13:276-284.
6. Eyckerman S., Verhee A., Van der Heyden J., Lemmens I., Van Ostade X., Vandekerckhove J., et al. Design and application of a cytokine-receptor-based interaction trap. Nat Cell Biol 2001, 3:1114-1119.
7. Montoye T., Piessevaux J., Lavens D., Wauman J., Catteeuw D., Vandekerckhove J., et al. Analysis of leptin signalling in hematopoietic cells using an adapted MAPPIT strategy. FEBS Lett 2006, 580:3301-3307.
8. Fields S. Interactive learning: lessons from two hybrids over two decades. Proteomics 2009.
9. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature 1989, 340:245-246.
10. Lievens S., Eyckerman S., Lemmens I., Tavernier J. Large-scale protein interactome mapping: strategies and opportunities. Expert Rev Proteomics 2010, 7:679-690.
11. Lievens S., Lemmens I., Tavernier J. Mammalian two-hybrids come of age. Trends Biochem Sci 2009, 34:579-588.
12. Petschnigg J., Snider J., Stagljar I. Interactive proteomics research technologies: recent applications and advances. Curr Opin Biotechnol 2011, 22:50-58.
13. Suter B., Kittanakom S., Stagljar I. Two-hybrid technologies in proteomics research. Curr Opin Biotechnol 2008, 19:316-323.
14. Braun P., Tasan M., Dreze M., Barrios-Rodiles M., Lemmens I., Yu H., et al. An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 2009, 6:91-97.
15. Lemmens I., Eyckerman S., Zabeau L., Catteeuw D., Vertenten E., Verschueren K., et al. Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells. Nucleic Acids Res 2003, 31.
16. Eyckerman S., Lemmens I., Catteeuw D., Verhee A., Vandekerckhove J., Lievens S., et al. Reverse MAPPIT: screening for protein-protein interaction modifiers in mammalian cells. Nat Methods 2005, 2:427-433.
17. Caligiuri M., Molz L., Liu Q., Kaplan F., Xu J.P., Majeti J.Z., et al. MASPIT: three-hybrid trap for quantitative proteome fingerprinting of small molecule-protein interactions in mammalian cells. Chem Biol 2006, 13:711-722.
18. Lievens S., Van der Heyden J., Vertenten E., Plum J., Vandekerckhove J., Tavernier J. Design of a fluorescence-activated cell sorting-based mammalian protein-protein interaction trap. Methods Mol Biol 2004, 263:293-310.
19. Lievens S., Vanderroost N., Van der Heyden J., Gesellchen V., Vidal M., Tavernier J. Array MAPPIT: high-throughput interactome analysis in mammalian cells. J Proteome Res 2009, 8:877-886.
20. Uyttendaele I, Lavens D, Catteeuw D, Tavernier J, Peelman F. Random mutagenesis MAPPIT analysis identifies binding sites for Vif and Gag in both cytidine deaminase domains of Apobec3G, in preparation.
21. Vidal M., Cusick M.E., Barabasi A.L. Interactome networks and human disease. Cell 2011, 144:986-998.
22. Erkeland S.J., Aarts L.H., Irandoust M., Roovers O., Klomp A., Valkhof M., et al. Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation and differentiation signaling. Oncogene 2007, 26:1985-1994.
23. Lavens D., Montoye T., Piessevaux J., Zabeau L., Vandekerckhove J., Gevaert K., et al. A complex interaction pattern of CIS and SOCS2 with the leptin receptor. J Cell Sci 2006, 119:2214-2224.
24. Lavens D., Ulrichts P., Catteeuw D., Gevaert K., Vandekerckhove J., Peelman F., et al. The C-terminus of CIS defines its interaction pattern. Biochem J 2007, 401:257-267.
25. Montoye T., Lemmens I., Catteeuw D., Eyckerman S., Tavernier J. A systematic scan of interactions with tyrosine motifs in the erythropoietin receptor using a mammalian 2-hybrid approach. Blood 2005, 105:4264-4271.
26. Palande K., Roovers O., Gits J., Verwijmeren C., Iuchi Y., Fuji J., et al. Peroxiredoxin-controlled G-CSF receptor signaling at the endoplasmic reticulum-early endosome interface. J Cell Sci 2011, 124(Pt 21):3695-3705.
27. Piessevaux J., De Ceuninck L., Catteeuw D., Peelman F., Tavernier J. Elongin B/C recruitment regulates substrate binding by CIS. J Biol Chem 2008, 283:21334-21346.
28. Piessevaux J., Lavens D., Montoye T., Peelman F., Tavernier J. Functional cross-modulation between SOCS proteins can stimulate cytokine signaling. J Biol Chem 2006, 281:32953-32966.
29. Piessevaux J., Lavens D., Peelman F., Tavernier J. The many faces of the SOCS box. Cytokine Growth Factor Rev 2008, 19:371-381.
30. Uyttendaele I., Lemmens I., Verhee A., De Smet A.S., Vandekerckhove J., Lavens D., et al. Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor. Mol Endocrinol 2007, 21:2821-2831.
31. Wauman J., De Smet A.S., Catteeuw D., Belsham D., Tavernier J. Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways. Mol Endocrinol 2008, 22:965-977.
32. Lemmens I., Lievens S., Tavernier J. MAPPIT: a versatile tool to study cytokine receptor signalling. Biochem Soc Trans 2008, 36:1448-1451.
33. Ulrichts P., Lemmens I., Lavens D., Beyaert R., Tavernier J. MAPPIT (mammalian protein-protein interaction trap) analysis of early steps in toll-like receptor signalling. Methods Mol Biol 2009, 517:133-144.
34. Ulrichts P., Tavernier J. MAPPIT analysis of early Toll-like receptor signalling events. Immunol Lett 2008, 116:141-148.
35. Ulrichts P., Peelman F., Beyaert R., Tavernier J. MAPPIT analysis of TLR adaptor complexes. FEBS Lett 2007, 581:629-636.
36. Ulrichts P., Bovijn C., Lievens S., Beyaert R., Tavernier J., Peelman F. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site. J Cell Sci 2010, 123:256-265.
37. Bovijn C, Ulrichts P, De Smet AS, Catteeuw D, Beyaert R, Tavernier J, et al. Identification of interaction sites for dimerization and adapter recruitment in the TLR4 TIR domain, submitted for publication.
38. Pattyn E., Lavens D., Van der Heyden J., Verhee A., Lievens S., Lemmens I., et al. MAPPIT (mammalian protein-protein interaction trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells. J Virol Methods 2008, 153:7-15.
39. Lavens D., Peelman F., Van der Heyden J., Uyttendaele I., Catteeuw D., Verhee A., et al. Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis. Nucleic Acids Res 2010, 38:1902-1912.
40. Yu H., Braun P., Yildirim M.A., Lemmens I., Venkatesan K., Sahalie J., et al. High-quality binary protein interaction map of the yeast interactome network. Science 2008, 322:104-110.
41. Simonis N., Rual J.F., Carvunis A.R., Tasan M., Lemmens I., Hirozane-Kishikawa T., et al. Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network. Nat Methods 2009, 6:47-54.
42. Venkatesan K., Rual J.F., Vazquez A., Stelzl U., Lemmens I., Hirozane-Kishikawa T., et al. An empirical framework for binary interactome mapping. Nat Methods 2009, 6:83-90.
43. Lemmens I., Lievens S., Tavernier J. Strategies towards high-quality binary protein interactome maps. J Proteomics 2010, 73:1415-1420.
44. Chen Y.C., Rajagopala S.V., Stellberger T., Uetz P. Exhaustive benchmarking of the yeast two-hybrid system. Nat Methods 2010, 7:667-668. [author reply 668].
45. Boxem M., Maliga Z., Klitgord N., Li N., Lemmens I., Mana M., et al. A protein domain-based interactome network for C. elegans early embryogenesis. Cell 2008, 134:534-545.
46. Wauman J., De Ceuninck L., Vanderroost N., Lievens S., Tavernier J. RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding. J Cell Sci 2011, 124:921-932.
47. Lievens S, Vanderroost N, Defever D, Van der Heyden J, Tavernier J. Array MAPPIT: a screening platform for human protein interactome analysis. Methods Mol Biol, in press.
48. Stumpf M.P., Thorne T., de Silva E., Stewart R., An H.J., Lappe M., et al. Estimating the size of the human interactome. Proc Natl Acad Sci USA 2008, 105:6959-6964.
49. Arkin M.R., Wells J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004, 3:301-317.
50. Wells J.A., McClendon C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450:1001-1009.
51. Zinzalla G., Thurston D.E. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. Future Med Chem 2009, 1:65-93.
52. Lemmens I., Lievens S., Eyckerman S., Tavernier J. Reverse MAPPIT detects disruptors of protein-protein interactions in human cells. Nat Protoc 2006, 1:92-97.
53. Milstein S., Vidal M. Perturbing interactions. Nat Methods 2005, 2:412-414.
54. Van Schoubroeck B, Van Acker K, Dams G, Jochmans D, Clayton R, Berke JM, et al. MAPPIT as a high-throughput screening assay for modulators of protein-protein interactions in HIV and HCV. Methods Mol Biol, in press.
55. Lievens S, Caligiuri M, Kley N, Tavernier J. The use of mammalian two-hybrids for high-throughput drug screening, submitted for publication.
56. Risseeuw MDP, Lievens S, Sinnaeve D, Martins JC, Tavernier J, Van Calenbergh S. Synthesis of a "Clickable" MTX-reagent as practical tool for profiling small molecule-intracellular target interactions via MASPIT. submitted for publication.
57. Yang X., Boehm J.S., Salehi-Ashtiani K., Hao T., Shen Y., Lubonja R., et al. A public genome-scale lentiviral expression library of human ORFs. Nat Methods 2011, 8:659-661.
58. Rantala J.K., Makela R., Aaltola A.R., Laasola P., Mpindi J.P., Nees M., et al. A cell spot microarray method for production of high density siRNA transfection microarrays. BMC Genomics 2011, 12:162.